Mannitol Intravenous Infusion (20%) & (10%)

Mannitol Intravenous Infusion (20%) & (10%) is a sterile intravenous solution designed for effective treatment in critical care settings. This infusion combines the osmotic diuretic properties of Mannitol with the protective and hydrating effects of Glycerine, providing a balanced solution for various medical conditions. Presented in a high-quality glass bottle, it ensures product stability and minimizes the risk of contamination.

Mannitol acts to reduce intracranial and intraocular pressure, making it invaluable in managing conditions such as cerebral edema, glaucoma, and acute renal failure. Glycerine, a natural humectant, helps maintain proper hydration and prevents dehydration during therapy. The combination of these two components enhances therapeutic efficacy while minimizing side effects.

Available Sizes :

100ml 250ml 500ml
QUICK INQUIRY NOW
Description

Description

Mannitol Intravenous Infusion (20%) & (10%) is a sterile intravenous solution designed for effective treatment in critical care settings. This infusion combines the osmotic diuretic properties of Mannitol with the protective and hydrating effects of Glycerine, providing a balanced solution for various medical conditions. Presented in a high-quality glass bottle, it ensures product stability and minimizes the risk of contamination.

Mannitol acts to reduce intracranial and intraocular pressure, making it invaluable in managing conditions such as cerebral edema, glaucoma, and acute renal failure. Glycerine, a natural humectant, helps maintain proper hydration and prevents dehydration during therapy. The combination of these two components enhances therapeutic efficacy while minimizing side effects.

Manufactured to the highest standards in accordance with British Pharmacopoeia (BP) guidelines, Mannitol 10% + Glycerine 10% Infusion BP is trusted by healthcare professionals for its reliability and safety. It is an essential product in intensive care units, emergency rooms, and other hospital settings.